Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug ...
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today ... risk/benefit balance that exceeds that of alternative treatments, should not increase ...
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S.
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...
An experimental treatment for depression that triggers seizures with magnets significantly improved mental health in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results